期刊文献+

减轻应激训练在肝癌经导管动脉化疗栓塞术后康复中的应用 被引量:1

下载PDF
导出
摘要 目的探讨减轻应激训练在肝癌患者经导管动脉化疗栓塞(TACE)术后康复中的应用效果。方法选择210例中晚期原发性肝癌患者为研究对象,所有患者均行TACE治疗,根据术后是否进行减轻应激训练将患者分为观察组(110例)和对照组(100例)。对照组予以常规对症治疗,观察组予以常规对症治疗联合减轻应激训练,比较两组患者术后疼痛程度(VAS评分),术前及术后肝功能相关指标[丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和总胆红素(TBIL)]水平、集落刺激因子(CSF)-1水平和乙肝应激量表(PSSH)评分。结果术后2周,两组患者AST、ALT、TBIL、CSF-1水平和PSSH评分均较术前降低(均P<0.05),且观察组患者AST、ALT、TBIL、CSF-1水平和PSSH评分均低于对照组(均P<0.05)。术后第1天两组患者的VAS评分差异无统计学意义(P>0.05),术后第14天两组患者的VAS评分均较术后第1天降低(均P<0.05),且观察组VAS评分低于对照组(P<0.05)。结论将减轻应激训练应用于肝癌患者TACE术后康复治疗中,能够有效减轻患者的应激反应,提高肿瘤治疗效果,改善患者疼痛程度和肝功能。
作者 唐秀鹏 游波
出处 《微创医学》 2022年第3期376-379,共4页 Journal of Minimally Invasive Medicine
  • 相关文献

参考文献12

二级参考文献126

  • 1Walter M, Dammann G, Papachristou C, et al. Quality of life of living donors before and after living donor liver transplantation. Transplant Proc ,2003,35 ( 8 ) :2961 - 2963.
  • 2Basaran O, Karakayali H, Emiroglu R, et al. Donor safety and quality of life after left hepatic lobe donation in living-donor liver transplantation. Transplant Proe,2003,35 (4) :2768 - 2769.
  • 3Martin RC, Eid S, Scoggins CR, et at. Health-related quality of life: return to baseline after major and minor liver resection. Surgery ,2007,142 ( 5 ) :676 - 684.
  • 4Bianchi G, Loguercio C, Sgarbi D, et al. Reduced quality of life of patients with hepatocellular carcinoma. Dig Liver Dis,2003,35 (1) :46 -54.
  • 5Dmitrewski J, EI-Gazzaz G, MeMaster P. Hepatocellular cancer: resection or transplantation. J Hepatobiliary Pancreat Surg,1998,5 (1):18-23.
  • 6Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancers : the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol,2002,20 (9) :2229 - 2239.
  • 7Lang K, Danchenko N, Gondek K, et al. The burden of illness associated with hepatocellular carcinoma in the United States. Hepatology ,2009,50 ( 1 ) :89 - 99.
  • 8Sagmeister M, Mullhaupt B, Kadry Z, et al. Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation, 2002,73(6) :616 -622.
  • 9Sarasin FP, Majno PE, Liovet JM, et al. Living donor liver transplantation for early hepatocelluar carcinoma : A life-expectancy and cost-effectiveness perspective. Hepatology, 2001 , 33 (5) : 1073 - 1079.
  • 10Pisati R, Ferrara R, Mosca F, et al. Cost and outcome evaluation of liver transplantation at Cisanello Hospital: ( 1 ) Methods for data analysis. Transplant Proc ,2003,35 (3) : 1038 - 1040.

共引文献98

同被引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部